Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Summary
The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of Differential Target Multiplexed (DTM®) programming in the Spinal Cord Stimulation (SCS) implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celéri Health and is funded through a financial grant from Medtronic's External Research Program. The registry study will be conducted across approximately 25 centers in the United States with up to 600 participants enrolled.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
To evaluate the longitudinal characterization of objective posture and activity measures.
Find a Location
Who is running the clinical trial?
Celéri Health, Inc.Lead Sponsor
2 Previous Clinical Trials
123 Total Patients Enrolled
2 Trials studying Chronic Pain
123 Patients Enrolled for Chronic Pain
MedtronicIndustry Sponsor
613 Previous Clinical Trials
759,478 Total Patients Enrolled
4 Trials studying Chronic Pain
1,921 Patients Enrolled for Chronic Pain
Michael Fishman, MDStudy DirectorChief Medical Officer
3 Previous Clinical Trials
177 Total Patients Enrolled
2 Trials studying Chronic Pain
170 Patients Enrolled for Chronic Pain
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger